Stay updated on ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T19:49:32.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Fallopian tube cancer was added to the study's conditions, and the page revision was updated to v3.4.2 (v3.4.1 was removed).
    Difference
    0.1%
    Check dated 2026-02-12T01:39:54.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.4.1 replaces Revision: v3.4.0 on the page, which is a minor update to the revision label and does not affect study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T22:39:12.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary display, the 'Last Update Submitted that Met QC Criteria' label, 'No FEAR Act Data' notice, and Revision: v3.4.0. Removed the older items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T21:28:20.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:30:25.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page now lists expanded recruitment locations, including US states (Colorado, Massachusetts, Missouri, New York, North Carolina, Rhode Island, Tennessee, Texas) and Australian regions (Queensland, South Australia, Victoria, Western Australia).
    Difference
    1%
    Check dated 2025-12-23T21:09:03.000Z thumbnail image

Stay in the know with updates to ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page.